Safety and Efficacy of Azelaic Acid Foam, 15% in Papulopustular Rosacea
Public ClinicalTrials.gov record NCT01025635. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Randomized, Double-blind, Vehicle-controlled, Multicenter, Parallel-group Study to Investigate Safety and Efficacy of Azelaic Acid Foam, 15% Topically Applied Twice Daily in Subjects With Papulopustular Rosacea
Study identification
- NCT ID
- NCT01025635
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- LEO Pharma
- Industry
- Enrollment
- 401 participants
Conditions and interventions
Conditions
Interventions
- Azelaic acid foam 15% Drug
- Vehicle foam Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Nov 30, 2009
- Primary completion
- Jul 31, 2010
- Completion
- Jul 31, 2010
- Last update posted
- Mar 30, 2020
2009 – 2010
United States locations
- U.S. sites
- 20
- U.S. states
- 13
- U.S. cities
- 19
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Not listed | Birmingham | Alabama | 35209 | — |
| Not listed | Birmingham | Alabama | 35233 | — |
| Not listed | Fremont | California | 94538 | — |
| Not listed | Santa Monica | California | 90404 | — |
| Not listed | Miami | Florida | 33175 | — |
| Not listed | Miramar | Florida | 33027 | — |
| Not listed | Omaha | Nebraska | 68144 | — |
| Not listed | Albuquerque | New Mexico | 87106 | — |
| Not listed | High Point | North Carolina | 27262 | — |
| Not listed | Wilmington | North Carolina | 28401 | — |
| Not listed | Winston-Salem | North Carolina | 27103 | — |
| Not listed | Portland | Oregon | 97210 | — |
| Not listed | Johnston | Rhode Island | 02919 | — |
| Not listed | Simpsonville | South Carolina | 29681 | — |
| Not listed | Knoxville | Tennessee | 37922 | — |
| Not listed | Nashville | Tennessee | 37215 | — |
| Not listed | Austin | Texas | 78759 | — |
| Not listed | Plano | Texas | 75093 | — |
| Not listed | Salt Lake City | Utah | 84124 | — |
| Not listed | Madison | Wisconsin | 53719 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01025635, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Mar 30, 2020 · Synced Jul 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT01025635 live on ClinicalTrials.gov.